Startseite UB

Browse by Person

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | No Grouping
Jump to: Article
Number of items: 54.

Article

Reinert, C. and Kremmler, L. and Burock, S. and Bogdahn, Ulrich and Wick, W. and Gleiter, C.H. and Koller, M. and Hau, Peter (2014) Quantitative and qualitative analysis of study-related patient information sheets in randomized neuro-oncology phase III-trials. European Journal of Cancer. (In Press)

Kreutz, Marina and Gottfried, Eva and Lang, Sven A. and Renner, Kathrin and Bosserhoff, Anja-Katrin and Gronwald, Wolfram and Rehli, Michael and Einhell, Sabine and Gedig, Isabell and Singer, Katrin and Seilbeck, Anton and Mackensen, Andreas and Grauer, Oliver and Hau, Peter and Dettmer, Katja and Andreesen, Reinhard and Oefner, Peter (2013) New aspects of an old drug: Diclofenac targets MYC and glucose metabolism in tumor cells. PLoS ONE 8 (7), e66987.

Ramm Sander, Paul and Hau, Peter and Koch, Steffen and Schütze, Karin and Bogdahn, Ulrich and Kalbitzer, Hans Robert and Aigner, Ludwig (2013) Stem cell metabolic and spectroscopic profiling. Trends in biotechnology 31 (3), pp. 204-213.

Chirasani, Sridhar Reddy and Leukel, Petra and Gottfried, Eva and Hochrein, Jochen and Stadler, Katrin and Neumann, Bernhard and Oefner, Peter J. and Gronwald, Wolfram and Bogdahn, Ulrich and Hau, Peter and Kreutz, Marina and Grauer, Oliver M. (2013) Diclofenac inhibits lactate formation and efficiently counteracts local immune suppression in a murine glioma model. International journal of cancer. Journal international du cancer 132 (4), pp. 843-53.

Chirasani, Sridhar R. and Leukel, Petra and Gottfried, Eva and Hochrein, Jochen and Stadler, Katrin and Neumann, Bernhard and Oefner, Peter J. and Gronwald, Wolfram and Bogdahn, Ulrich and Hau, Peter and Kreutz, Marina and Grauer, Oliver M. (2013) Diclofenac inhibits lactate formation and efficiently counteracts local immune suppression in a murine glioma model. International journal of cancer 132 (4), pp. 843-853.

Uhl, M. and Hau, Peter (2013) High-Grade Glioma: Refined Diagnostics Steering Stratified Therapy. Case reports in oncology 6 (2), pp. 387-389.

Seliger, Corinna and Leukel, Petra and Moeckel, Sylvia and Jachnik, Birgit and Lottaz, Claudio and Kreutz, Marina and Brawanski, Alexander and Proescholdt, Martin and Bogdahn, Ulrich and Bosserhoff, Anja-Katrin and Vollmann-Zwerenz, Arabel and Hau, Peter (2013) Lactate-Modulated Induction of THBS-1 Activates Transforming Growth Factor (TGF)-beta2 and Migration of Glioma Cells In Vitro. PloS one 8 (11), e78935.

Uhl, M. and Hau, Peter (2013) Neues aus der Neuroonkologie. Aktuelle Neurologie 40 (4), pp. 180-184.

Hutterer, Markus and Steurer, Michael and Höftberger, Romana and Hainfellner, Johannes A. and Pircher, Andreas and Nowosielski, Martha and Hau, Peter and Löscher, Wolfgang and Gunsilius, Eberhard and Berger, Thomas and Stockhammer, Guenther (2013) Polyarteritis nodosa complicating multiple myeloma - a case report and review of the literature. Clinical neuropathology.

Riemenschneider, Markus J. and Louis, David N. and Weller, Michael and Hau, Peter (2013) Refined brain tumor diagnostics and stratified therapies: the requirement for a multidisciplinary approach. Acta neuropathologica 126 (1), pp. 21-37.

Friedrich, Carsten and von Bueren, André O and von Hoff, Katja and Kwiecien, Robert and Pietsch, Torsten and Warmuth-Metz, Monika and Hau, Peter and Deinlein, Frank and Kuehl, Joachim and Kortmann, Rolf D and Rutkowski, Stefan (2013) Treatment of adult nonmetastatic medulloblastoma patients according to the paediatric HIT 2000 protocol: a prospective observational multicentre study. European journal of cancer 49 (4), pp. 893-903.

Beier, Christoph P. and Kumar, Praveen and Meyer, Katharina and Leukel, Petra and Bruttel, Valentin and Aschenbrenner, Ines and Riemenschneider, Markus J. and Fragoulis, Athanassios and Rümmele, Petra and Lamszus, Katrin and Schulz, Jörg B. and Weis, Joachim and Bogdahn, Ulrich and Wischhusen, Jörg and Hau, Peter and Spang, Rainer and Beier, Dagmar (2012) The cancer stem cell subtype determines immune infiltration of glioblastoma. Stem Cells and Development 21 (15), pp. 2753-2761.

Ramm, Paul and Bettscheider, Marc and Beier, Dagmar and Kalbitzer, Hans Robert and Kremer, Werner and Bogdahn, Ulrich and Hau, Peter and Aigner, Ludwig and Beier, Christoph P. (2011) 1H-nuclear magnetic resonance spectroscopy of glioblastoma cancer stem cells. Stem cells and development 20 (12), pp. 2189-2195.

Stupp, R. and Tosoni, A. and Bromberg, J. E. C. and Hau, Peter and Campone, M. and Gijtenbeek, J. and Frenay, M. and Breimer, L. and Wiesinger, H. and Allgeier, A. and van den Bent, M. J. and Bogdahn, Ulrich and van der Graaf, W. and Yun, H. J. and Gorlia, T. and Lacombe, D. and Brandes, A. A. (2011) Sagopilone (ZK-EPO, ZK 219477) for recurrent glioblastoma. A phase II multicenter trial by the European Organisation for Research and Treatment of Cancer (EORTC) Brain Tumor Group. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 22 (9), pp. 2144-2149.

Hau, Peter and Jachimczak, Piotr and Schlaier, Jürgen and Bogdahn, Ulrich (2011) TGF-β2 signaling in high-grade gliomas. Current pharmaceutical biotechnology 12 (12), pp. 2150-2157.

Bogdahn, Ulrich and Hau, Peter and Stockhammer, G. and Venkataramana, N. K. and Mahapatra, A. K. and Suri, A. and Balasubramaniam, A. and Nair, S. and Oliushine, V. and Parfenov, V. and Poverennova, I. and Zaaroor, M. and Jachimczak, P. and Ludwig, S. and Schmaus, S. and Heinrichs, H. and Schlingensiepen, K-H. (2011) Targeted therapy for high-grade glioma with the TGF-β2 inhibitor trabedersen: results of a randomized and controlled phase IIb study. Neuro-oncology 13 (1), pp. 132-142.

Grauer, Oliver and Pascher, Christina and Hartmann, Christian and Zeman, Florian and Weller, Michael and Proescholdt, Martin A. and Brawanski, Alexander and Pietsch, Thorsten and Wick, Wolfgang and Bogdahn, Ulrich and Hau, Peter (2011) Temozolomide and 13-cis retinoic acid in patients with anaplastic gliomas: a prospective single-arm monocentric phase-II study (RNOP-05). Journal of neuro-oncology 104 (3), pp. 801-809.

Wismeth, Caecilia and Dudel, Christine and Pascher, Christina and Ramm, Paul and Pietsch, Torsten and Hirschmann, Birgit and Reinert, Christiane and Proescholdt, Martin A. and Rümmele, Petra and Schuierer, Gerhard and Bogdahn, Ulrich and Hau, Peter (2010) Transcranial electro-hyperthermia combined with alkylating chemotherapy in patients with relapsed high-grade gliomas: phase I clinical results. Journal of neuro-oncology 98 (3), pp. 395-405.

Stupp, Roger and Hegi, Monika E. and Mason, Warren P. and van den Bent, Martin J. and Taphoorn, Martin J. B. and Janzer, Robert C. and Ludwin, Samuel K. and Allgeier, Anouk and Fisher, Barbara and Belanger, Karl and Hau, Peter and Brandes, Alba A. and Gijtenbeek, Johanna and Marosi, Christine and Vecht, Charles J. and Mokhtari, Karima and Wesseling, Pieter and Villa, Salvador and Eisenhauer, Elizabeth and Gorlia, Thierry and Weller, Michael and Lacombe, Denis and Cairncross, J. Gregory and Mirimanoff, René-Olivier (2009) Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. The lancet oncology 10 (5), pp. 459-466.

Baumann, Fusun and Leukel, Petra and Doerfelt, Anett and Beier, Christoph P. and Dettmer, Katja and Oefner, Peter J. and Kastenberger, Michael and Kreutz, Marina and Nickl-Jockschat, Thomas and Bogdahn, Ulrich and Bosserhoff, Anja-Katrin and Hau, Peter (2009) Lactate promotes glioma migration by TGF-beta2-dependent regulation of matrix metalloproteinase-2. Neuro-oncology 11 (4), pp. 368-380.

Reardon, D. A. and Dresemann, G. and Taillibert, S. and Campone, M. and van den Bent, M. and Clement, P. and Blomquist, E. and Gordower, L. and Schultz, H. and Raizer, J. and Hau, Peter and Easaw, J. and Gil, M. and Tonn, J. and Gijtenbeek, A. and Schlegel, U. and Bergstrom, P. and Green, S. and Weir, A. and Nikolova, Z. (2009) Multicentre phase II studies evaluating imatinib plus hydroxyurea in patients with progressive glioblastoma. British journal of cancer 101 (12), pp. 1995-2004.

Beier, Christoph P. and Schmid, Christina and Gorlia, Thierry and Kleinletzenberger, Christine and Beier, Dagmar and Grauer, Oliver and Steinbrecher, Andreas and Hirschmann, Birgit and Brawanski, Alexander and Dietmaier, Christopher and Jauch-Worley, Tanja and Kölbl, Oliver and Pietsch, Torsten and Proescholdt, Martin A. and Rümmele, Petra and Muigg, Armin and Stockhammer, Günther and Hegi, Monika and Bogdahn, Ulrich and Hau, Peter (2009) RNOP-09: pegylated liposomal doxorubicine and prolonged temozolomide in addition to radiotherapy in newly diagnosed glioblastoma--a phase II study. BMC cancer 9, p. 308.

Wick, Antje and Pascher, Christina and Wick, Wolfgang and Jauch, Tanja and Weller, Michael and Bogdahn, Ulrich and Hau, Peter (2009) Rechallenge with temozolomide in patients with recurrent gliomas. Journal of neurology 256 (5), pp. 734-741.

Hau, Peter and Jachimczak, Piotr and Bogdahn, Ulrich (2009) Treatment of malignant gliomas with TGF-beta2 antisense oligonucleotides. Expert review of anticancer therapy 9 (11), pp. 1663-1674.

Beier, Dagmar and Wischhusen, Jörg and Dietmaier, Wolfgang and Hau, Peter and Proescholdt, Martin A. and Brawanski, Alexander and Bogdahn, Ulrich and Beier, Christoph P. (2008) CD133 expression and cancer stem cells predict prognosis in high-grade oligodendroglial tumors. Brain pathology 18 (3), pp. 370-377.

Glas, Martin and Hennemann, Burkhard and Hirschmann, Birgit and Marienhagen, Jörg and Schmidt-Wolf, Ingo and Herrlinger, Ulrich and Bogdahn, Ulrich and Hau, Peter (2008) Complete response after treatment with a somatostatin analogue in an adult patient with recurrent medulloblastoma. Acta oncologica 47 (3), pp. 479-480.

Wagner, Sabine and Peters, Ove and Fels, Christin and Janssen, Gisela and Liebeskind, Anne-Kathrin and Sauerbrey, Axel and Suttorp, Meinolf and Hau, Peter and Wolff, Johannes E. A. (2008) Pegylated-liposomal doxorubicin and oral topotecan in eight children with relapsed high-grade malignant brain tumors. Journal of neuro-oncology 86 (2), pp. 175-181.

Goerne, Rainer and Bogdahn, Ulrich and Hau, Peter (2008) Procarbazine--a traditional drug in the treatment of malignant gliomas. Current medicinal chemistry 15 (14), pp. 1376-1387.

Beier, Dagmar and Röhrl, Stefanie and Pillai, Deepu R. and Schwarz, Stefanie and Kunz-Schughart, Leoni A. and Leukel, Petra and Proescholdt, Martin A. and Brawanski, Alexander and Bogdahn, Ulrich and Trampe-Kieslich, Ariane and Giebel, Bernd and Wischhusen, Jörg and Reifenberger, Guido and Hau, Peter and Beier, Christoph P. (2008) Temozolomide preferentially depletes cancer stem cells in glioblastoma. Cancer research 68 (14), pp. 5706-5715.

Ickenstein, G. W. and Valaikiene, J. and Koch, H. and Hau, Peter and Erban, P. and Schlachetzki, F. (2008) Ultrasonic contrast agents in transcranial perfusion sonography (TPS) for follow-up of patients with high grade gliomas. Ultrasonics sonochemistry 15 (4), pp. 510-516.

Nickl-Jockschat, T. and Arslan, F. and Doerfelt, A. and Bogdahn, U. and Bosserhoff, A. and Hau, Peter (2007) An imbalance between Smad and MAPK pathways is responsible for TGF-beta tumor promoting effects in high-grade gliomas. International journal of oncology 30 (2), pp. 499-507.

Beier, Dagmar and Hau, Peter and Proescholdt, Martin A. and Lohmeier, Annette and Wischhusen, Jörg and Oefner, Peter J. and Aigner, Ludwig and Brawanski, Alexander and Bogdahn, Ulrich and Beier, Christoph P. (2007) CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles. Cancer research 67 (9), pp. 4010-4015.

Hau, Peter and Jachimczak, Piotr and Schlingensiepen, Reimar and Schulmeyer, Frank and Jauch, Tanya and Steinbrecher, Andreas and Brawanski, Alexander and Proescholdt, Martin A. and Schlaier, Jürgen and Buchroithner, Johanna and Pichler, Josef and Wurm, Gabriele and Mehdorn, Maximilian and Strege, Rainer and Schuierer, Gerhard and Villarrubia, Victoria and Fellner, Franz and Jansen, Olav and Straube, Thorsten and Nohria, Virinder and Goldbrunner, Michael and Kunst, Mechthild and Schmaus, Susanne and Stauder, Gerhard and Bogdahn, Ulrich and Schlingensiepen, Karl-Hermann (2007) Inhibition of TGF-beta2 with AP 12009 in recurrent malignant gliomas: from preclinical to phase I/II studies. Oligonucleotides 17 (2), pp. 201-212.

Hau, Peter and Kunz-Schughart, L. and Bogdahn, U. and Baumgart, U. and Hirschmann, B. and Weimann, E. and Muhleisen, H. and Ruemmele, P. and Steinbrecher, A. and Reichle, A. (2007) Low-dose chemotherapy in combination with COX-2 inhibitors and PPAR-gamma agonists in recurrent high-grade gliomas - a phase II study. Oncology 73 (1-2), pp. 21-25.

Hau, Peter and Stupp, Roger and Hegi, Monika E. (2007) MGMT methylation status: the advent of stratified therapy in glioblastoma? Disease markers 23 (1-2), pp. 97-104.

Glas, Martin and Koch, Horst and Hirschmann, Birgit and Jauch, Tanja and Steinbrecher, Andreas and Herrlinger, Ulrich and Bogdahn, Ulrich and Hau, Peter (2007) Pegylated liposomal doxorubicin in recurrent malignant glioma: analysis of a case series. Oncology 72 (5-6), pp. 302-307.

Hau, Peter and Koch, D. and Hundsberger, T. and Marg, E. and Bauer, B. and Rudolph, R. and Rauch, M. and Brenner, A. and Rieckmann, P. and Schuth, J. and Jauch, T. and Koch, H. and Bogdahn, U. (2007) Safety and feasibility of long-term temozolomide treatment in patients with high-grade glioma. Neurology 68 (9), pp. 688-690.

Arslan, F. and Bosserhoff, A.-K. and Nickl-Jockschat, T. and Doerfelt, A. and Bogdahn, U. and Hau, Peter (2007) The role of versican isoforms V0/V1 in glioma migration mediated by transforming growth factor-beta2. British journal of cancer 96 (10), pp. 1560-1568.

Hau, Peter and Kunz-Schughart, Leoni A. and Rümmele, Petra and Arslan, Füsun and Dörfelt, Anett and Koch, Horst and Lohmeier, Annette and Hirschmann, Birgit and Müller, Adolf and Bogdahn, Ulrich and Bosserhoff, Anja-Katrin (2006) Tenascin-C protein is induced by transforming growth factor-beta1 but does not correlate with time to tumor progression in high-grade gliomas. Journal of neuro-oncology 77 (1), pp. 1-7.

Koch, H. J. and Klinkhammer-Schalke, M. and Hofstädter, F. and Bogdahn, U. and Hau, Peter (2006) Seasonal patterns of birth in patients with glioblastoma. Chronobiology international 23 (5), pp. 1047-1052.

Herrlinger, Ulrich and Steinbrecher, A. and Rieger, J. and Hau, Peter and Kortmann, R.-D. and Meyermann, R. and Schabet, M. and Bamberg, M. and Dichgans, J. and Bogdahn, U. and Weller, M. (2005) Adult medulloblastoma: prognostic factors and response to therapy at diagnosis and at relapse. Journal of neurology 252 (3), pp. 291-299.

Jachimczak, Piotr and Apfel, Rainer and Bosserhoff, Anja-Kathrin and Fabel, Klaus and Hau, Peter and Tschertner, Ines and Wise, Petra and Schlingensiepen, Karl-Hermann and Schuler-Thurner, Beatrix and Bogdahn, Ulrich (2005) Inhibition of immunosuppressive effects of melanoma-inhibiting activity (MIA) by antisense techniques. International journal of cancer. Journal international du cancer 113 (1), pp. 88-92.

Schlingensiepen, Reimar and Goldbrunner, Michael and Szyrach, Mara N. I. and Stauder, Gerhard and Jachimczak, Piotr and Bogdahn, Ulrich and Schulmeyer, Frank and Hau, Peter and Schlingensiepen, Karl-Hermann (2005) Intracerebral and intrathecal infusion of the TGF-beta 2-specific antisense phosphorothioate oligonucleotide AP 12009 in rabbits and primates: toxicology and safety. Oligonucleotides 15 (2), pp. 94-104.

Hegi, Monika E. and Diserens, Annie-Claire and Gorlia, Thierry and Hamou, Marie-France and de Tribolet, Nicolas and Weller, Michael and Kros, Johan M. and Hainfellner, Johannes A. and Mason, Warren and Mariani, Luigi and Bromberg, Jacoline E. C. and Hau, Peter and Mirimanoff, René O. and Cairncross, J. Gregory and Janzer, Robert C. and Stupp, Roger (2005) MGMT gene silencing and benefit from temozolomide in glioblastoma. The New England journal of medicine 352 (10), pp. 997-1003.

Hau, Peter and Ruemmele, Petra and Kunz-Schughart, Leoni A. and Doerfelt, Anett and Hirschmann, Birgit and Lohmeier, Annette and Koch, Horst and Mueller, Adolf and Bogdahn, Ulrich and Bosserhoff, Anja-Katrin (2004) Expression levels of melanoma inhibitory activity correlate with time to progression in patients with high-grade glioma. Oncology reports 12 (6), pp. 1355-1364.

Kleiter, I. and Hans, V. H. and Schuierer, G. and Marienhagen, J. and Hau, Peter and Schütz, H. and Bogdahn, U. and Steinbrecher, A. (2004) Intraventricular cytarabine in a case of idiopathic hypertrophic pachymeningitis. Journal of neurology, neurosurgery, and psychiatry 75 (9), pp. 1346-1348.

Wismeth, Caecilia and Hau, Peter and Fabel, Klaus and Baumgart, Ulrike and Hirschmann, Birgit and Koch, Horst and Jauch, Tanja and Grauer, Oliver and Drechsel, Lisa and Brawanski, Alexander and Bogdahn, Ulrich and Steinbrecher, Andreas (2004) Maintenance therapy with 13-cis retinoid acid in high-grade glioma at complete response after first-line multimodal therapy--a phase-II study. Journal of neuro-oncology 68 (1), pp. 79-86.

Hau, Peter and Fabel, Klaus and Baumgart, Ulrike and Rümmele, Petra and Grauer, Oliver and Bock, Annekatrin and Dietmaier, Christopher and Dietmaier, Wolfgang and Dietrich, Jörg and Dudel, Christine and Hübner, Franz and Jauch, Tanya and Drechsel, Elisabeth and Kleiter, Ingo and Wismeth, Cäcile and Zellner, Anton and Brawanski, Alexander and Steinbrecher, Andreas and Marienhagen, Jörg and Bogdahn, Ulrich (2004) Pegylated liposomal doxorubicin-efficacy in patients with recurrent high-grade glioma. Cancer 100 (6), pp. 1199-1207.

Hau, Peter and Baumgart, Ulrike and Pfeifer, Katharina and Bock, Anne and Jauch, Tanya and Dietrich, Jörg and Fabel, Klaus and Grauer, Oliver and Wismeth, Caecilia and Klinkhammer-Schalke, Monika and Allgäuer, Michael and Schuierer, Gerhard and Koch, Horst and Schlaier, Juergen and Ulrich, Winfried and Brawanski, Alexander and Bogdahn, Ulrich and Steinbrecher, Andreas (2003) Salvage therapy in patients with glioblastoma: is there any benefit? Cancer 98 (12), pp. 2678-2686.

Hau, Peter and Dietrich, Joerg and Fabel, Klaus and Bogdahn, Ulrich (2002) Advances in the therapy of high-grade glioma at relapse: pegylated liposomal doxorubicin. Expert review of neurotherapeutics 2 (5), pp. 609-615.

Hau, Peter and Wise, Petra and Bosserhoff, Anja-Katrin and Blesch, Armin and Jachimczak, Piotr and Tschertner, Ines and Bogdahn, Ulrich and Apfel, Rainer (2002) Cloning and characterization of the expression pattern of a novel splice product MIA (splice) of malignant melanoma-derived growth-inhibiting activity (MIA/CD-RAP) [corrected]. The Journal of investigative dermatology 119 (3), pp. 562-569.

Hau, Peter and Apfel, Rainer and Wiese, Petra and Tschertner, Ines and Blesch, Armin and Bogdahn, Ulrich (2002) Melanoma-inhibiting activity (MIA/CD-RAP) is expressed in a variety of malignant tumors of mainly neuroectodermal origin. Anticancer research 22 (2A), pp. 577-583.

Fabel, K. and Dietrich, J. and Hau, Peter and Wismeth, C. and Winner, B. and Przywara, S. and Steinbrecher, A. and Ullrich, W. and Bogdahn, U. (2001) Long-term stabilization in patients with malignant glioma after treatment with liposomal doxorubicin. Cancer 92 (7), pp. 1936-1942.

Schlingensiepen, Karl-Hermann and Schlingensiepen, Reimar and Steinbrecher, Andreas and Hau, Peter and Bogdahn, Ulrich and Fischer-Blass, Birgit and Jachimczak, Piotr Targeted tumor therapy with the TGF-beta2 antisense compound AP 12009. Cytokine & growth factor reviews 17 (1-2), pp. 129-139.

This list was generated on Sat Aug 30 04:14:08 2014 CEST.
  1. University

University Library

Publication Server

Contact person
Gernot Deinzer

Telefon 0941 943-2759
Contact